BioCentury
ARTICLE | Company News

EC approves GlaxoSmithKline's avian flu vaccine

May 20, 2008 1:11 AM UTC

The European Commission approved an MAA from GlaxoSmithKline (LSE:GSK; NYSE:GSK) for Prepandrix, a split inactivated H5N1 influenza vaccine for use before a pandemic is declared. GlaxoSmithKline said ...